Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.73 |
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.73 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9195816 | 0.87 | SMN1; SMN2 (0.79) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL13863981 | 0.86 | SMN1; SMN2 (0.63) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL15272302 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL27477472 | 0.81 | SMN1; SMN2 (0.77) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL14595149 | 0.81 | SMN1; SMN2 (0.77) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL6978766 | 0.79 | ALDH1A1 (0.64) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL23451476 | 0.79 | SMN1; SMN2 (0.63) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL8158596 | 0.79 | HSD17B10 (0.63) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL27477057 | 0.78 | NPC1 (0.73) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL14491136 | 0.78 | ALDH1A1 (0.62) | SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0137228-B1 | PHOTOPOLYMERIZABLE COMPOSITION | FUJI PHOTO FILM CO., LTD. (JP) | 1988-10-05 | — | — | EP | claimed |
| EP-2067778-B1 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LAB (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-8216696-B2 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-8216696-B2 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-8183276-B2 | Therapeutic agents | MERCK SHARP & DOHME CORP. | 2012-05-22 | — | — | US | disclosed |
| US-20100324029-A1 | THERAPEUTIC AGENTS | MERCK SHARP & DOHME CORP. | 2010-12-23 | — | — | US | disclosed |
| US-20090153041-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-18 | — | — | US | disclosed |
| US-20090153041-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090153041-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same | SLC1A2, SLC18A2, SLC18A3 | SMN1; SMN2 4124/4885ALDH1A1 1610/4885HPGD 2143/4885 |
| US-20100324029-A1 | THERAPEUTIC AGENTS | PSEN2, PSEN1, BACE2 | SMN1; SMN2 233/4885ALDH1A1 1185/4885HPGD 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.